[CAS NO. 1047953-91-2]  MI-2 (MALT1 inhibitor)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1047953-91-2]

Store
Catalog
SLK-S7429
Brand
Selleck
CAS
1047953-91-2

DESCRIPTION [1047953-91-2]

Overview

MDLMFCD19754074
Molecular Weight455.72
Molecular FormulaC19H17Cl3N4O3
SMILESO=C(NC1=CC=C(N2N=C(OCCOC)N=C2C3=CC=C(Cl)C(Cl)=C3)C=C1)CCl

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.1943 mL10.9716 mL21.9433 mL
5 mM0.4389 mL2.1943 mL4.3887 mL
10 mM0.2194 mL1.0972 mL2.1943 mL
50 mM0.0439 mL0.2194 mL0.4389 mL

Description

MI-2 (MALT1 inhibitor) is an irreversible inhibitor with of 5.84 μM.

Targets

MALT1 [1]
(cell-free assay)
5.84 μM

In vitro

MI-2 inhibits MALT1 functions in ABC-DLBCL cell lines with excellent cell penetration. MI-2 produces selective growth inhibition for MALT1-dependent cell lines with GI50 of 0.2, 0.5, 0.4, and 0.4 礛 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells, whereas the ABC-DLBCL MALT1-independent cell lines, U2932 and HLY-1, and the two GCB-DLBCL cell lines were resistant.

In vivo

MI-2 (350 mg/kg) is nontoxic to mice. MI-2 (25 mg/kg/day i.p.) profoundly suppresses the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts, whereas it has no effect on the growth of OCI-Ly1 tumors.